Fusion of SARS-CoV-2 neutralizing LCB1 peptide with Bacillus amyloliquefaciens RNase improves antiviral efficacy

Nikita N. Kostin

Department of Peptide and Protein Technologies, M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Tatyana V. Bobik

Elena V. Konovalova

Milita V. Kocharovskaya

Maria A. Simonova

Natalia Yu Rushkevich

Yuliana A. Mokrushina

George A. Skryabin

Roman S. Kalinin

Sergey I. Kovalchuk

Rustam H. Ziganshin

Group of Mass Spectrometry, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Leonid A. Kaluzhskiy

Oksana V. Gnedenko

Evgeniy O. Yablokov

Alexis S. Ivanov

Aleksandr S. Chernov

Vitaly A. Kazakov

Oksana N. Khokhlova

Arkady N. Murashev

Senlian Hong

Elena I. Shramova

Alexey A. Schulga

Ekaterina N. Lyukmanova

Mikhail P. Kirpichnikov

Ivan V. Smirnov

Department of Peptide and Protein Technologies, M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Alexey A. Belogurov

Yuri P. Rubtsov

Alexey V. Stepanov

Department of Integrative Structural and Computational Biology, The Scripps Research Institute

Hongkai Zhang

Frontiers Science Center for New Organic Matter, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences and Academy for Advanced Interdisciplinary Studies

Alexander G. Gabibov

Department of Peptide and Protein Technologies, M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Sergey M. Deyev